Tarsus Pharmaceuticals announced that it expects to present 11 scientific abstracts at the American Academy of Optometry (AAOpt) 2026 Annual Meeting, taking place Sept. 30-Oct. 3 in Anaheim, California.

The planned abstracts provide new insights into the patient burden, diagnosis and treatment of Demodex blepharitis (DB); real-world experiences and outcomes with Xdemvy (lotilaner ophthalmic solution) 0.25%; and the prevalence and clinical characteristics of ocular rosacea. 

Accepted abstracts include:

Real-World Longitudinal Study of Patients with Demodex Blepharitis and Soft Contact Lens Wear in the United States: Interim Data Analysis (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: Anaheim Convention Center (ACC), Exhibit Hall
Presenter: Keith Wan, O.D.

Efficacy of Lotilaner 0.25% and Tea Tree Oil in Demodex Blepharitis: A Systematic Review and Meta-analysis (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: ACC, Exhibit Hall
Presenter: Ian B. Gaddie, O.D.

Retrospective Chart Review of Demodex Blepharitis Prevalence Among Patients with Chalazia and/or Hordeola (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: ACC, Exhibit Hall
Presenter: Andrew McLeod, O.D.

Prevalence of Ocular Rosacea in U.S. Eye Care Settings: A Multicenter Retrospective Chart Review (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: ACC, Exhibit Hall
Presenter: Mile Brujic, O.D.

Assessment of Dry Eye Questionnaires for Demodex Blepharitis: Evidence from a Targeted Literature Review (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: ACC, Exhibit Hall
Presenter: Walt Whitley, O.D.

Real-World Longitudinal Study of Patients with Demodex Blepharitis in the United States: 9-Month Follow-up Findings (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: ACC, Exhibit Hall
Presenter: Vanesa Flores, O.D.

Real-World Clinician Re-treatment Practices and Decision Drivers with Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: ACC, Exhibit Hall
Presenter: Cecelia Koetting, O.D.

Real-World Patient-Reported Satisfaction and Factors Associated with Perceived Benefit of Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: ACC, Exhibit Hall
Presenter: Jessilin Quint, O.D.

Associations Between Demodex Infestation and Meibomian Gland Structure and Function: A Systematic Review (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: ACC, Exhibit Hall
Presenter: Bridgitte Shen Lee, O.D.

Ocular Bacterial and Fungal Co-infestation in Demodex Infestation: A Systematic Review (Poster)
Date: Thursday, October 1, 2026, 4:30 – 6:30PM Pacific Daylight Time
Location: ACC, Exhibit Hall
Presenter: Pamela Theriot, O.D.

Assessment of Tea Tree-Based Management in Demodex Blepharitis: A Real-World Longitudinal Study (Paper)
Date: Friday, October 2, 2026, 4:00 – 4:15PM Pacific Daylight Time
Location: ACC, Room 255 C
Presenter: Selina McGee, O.D.